Parental use of 5-ASA for IBD before conception, during pregnancy safe for offspring

October 3, 2022

Paternal and maternal use of 5-aminosalicylic acid for treatment of Crohn’s disease or ulcerative colitis before conception and during pregnancy is safe, based on offspring outcomes in a nationwide Danish cohort study.“This study gives the first controlled results of different adverse birth outcomes after preconceptual paternal use of [], and it has the largest number of prescribed 5-ASA during pregnancy to date,” Bente Mertz Nørgård, MD, PhD, DMSc, chief physician and professor at the University of Southern Denmark and Odense University Hospital, and colleagues wrote inRead More

Categories: News

Related Articles

Paternal exposure to most IBD medications not linked to adverse neonatal outcomes

SAN DIEGO — Paternal exposure to the majority of therapies for inflammatory bowel disease did not increase the risk for adverse neonatal outcomes, according to…

2019 Telehealth Bill

In 2019, Florida passed the Telehealth Bill which establishes standards of practice for telehealth services, including patient evaluations, record-keeping, and controlled substances prescribing. The bill…

Justin Bouck July 9, 2019

Let’s Talk About Physician Burnout

Physician Burnout has become a serious topic of discussion in the healthcare field lately. With such a large array of factors affecting the well-being…

Justin Bouck June 5, 2018

IBD incidence, prevalence on the rise in Denmark with shift toward older patients

The incidence and prevalence of inflammatory bowel disease have increased in Denmark over the past two decades, most notably prevalence of ulcerative colitis among adults…

August 25, 2022

Cesarean delivery increases offspring’s risk for Crohn’s disease

People who were delivered by cesarean section were more likely to receive a Crohn’s disease diagnosis later in life compared with their vaginally delivered counterparts,…

August 25, 2022